MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Toward Objective Monitoring of Motor Fluctuations in Parkinson’s Disease: TMS-EEG Biomarkers

T. Fay-Karmon, T. Davidy, A. Suminski, A. Saar, N. Zifman, N. Fogel, S. Hassin-Baer (Ramat Gan, Israel)

Meeting: 2026 International Congress

Keywords: Neurophysiology, Parkinson’s, Transcranial magnetic stimulation(TMS)

Category: Parkinson's disease: Neuroimaging

Objective: Assess utility of TMS-EEG as objective markers for Motor fluctuations (MF) in Parkinson’s disease (PD).

Background: MF in PD are episodic changes in motor performance due to variable responses to levodopa therapy, marked by “on” and “off” periods. Current assessments rely on subjective patient reports and clinical observation, which may miss subtle changes. Neurophysiological markers obtained from transcranial magnetic stimulation combined with electroencephalography (TMS-EEG) hold promise as objective indicators of cortical excitability related to motor function.

Method: In a single visit, consecutive PD patients who are regularly treated with levodopa and experience significant MF, underwent a clinical assessment using the Movement Disorder Society-Unified PD Rating Scale (MDS-UPDRS), with part III rated in both “on” and “off” conditions. They also completed a TMS-EEG-based test called Delphi-MD in each state.

Results: Eighteen patients (mean age 59.4±19.1 years; 72.2% males; disease duration 10.8±8.8 years; LEDD 906.8±349.1 mg) participated. A repeated measures t-test showed that the TMS-EEG GMFP of the right primary motor cortex (M1R) significantly distinguished “on” vs. “off” states (p<0.000536). Regression analysis, controlled for LEDD, revealed that ∆GMFP N100 of primary visual cortex (V1R) variability explained about 49.9% of the variance in motor improvement (ΔMDS-UPDRS-III, F(2,13)=6.46, p=0.011, adjusted R²=0.42). Larger N100 amplitude increases in V1R (visual cortex) strongly predicted greater motor improvement (β=–0.79, p=0.003). LEDD showed a non-significant trend.

Conclusion: TMS-EEG measures from motor and occipital regions may serve as objective biomarkers of dopaminergic response in fluctuating PD. The motor cortex distinctly differentiates “on” and “off” states, while the visual cortex might provide real-time, continuous feedback on levodopa effects. These neurophysiological markers could reduce reliance on subjective assessments and improve monitoring and personalized treatment.

To cite this abstract in AMA style:

T. Fay-Karmon, T. Davidy, A. Suminski, A. Saar, N. Zifman, N. Fogel, S. Hassin-Baer. Toward Objective Monitoring of Motor Fluctuations in Parkinson’s Disease: TMS-EEG Biomarkers [abstract]. Mov Disord. 2026; 41 (suppl 1). https://www.mdsabstracts.org/abstract/toward-objective-monitoring-of-motor-fluctuations-in-parkinsons-disease-tms-eeg-biomarkers/. Accessed October 1, 2026.
  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to 2026 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/toward-objective-monitoring-of-motor-fluctuations-in-parkinsons-disease-tms-eeg-biomarkers/

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley